Literature DB >> 14991535

Muscle invasive schistosomal squamous cell carcinoma of the urinary bladder: frequency and prognostic significance of p53, BCL-2, HER2/neu, and proliferation (MIB-1).

Khaled M Badr1, J D L Nolen, Patricia B Derose, Cynthia Cohen.   

Abstract

Muscle invasion is the usual presentation of schistosomal squamous cell carcinoma of the urinary bladder. It is unclear whether this invasive behavior is secondary to the aggressive nature of the disease or to delay in diagnosis. Fixed paraffin-embedded hematoxylin and eosin-stained sections of 15 cystectomy specimens from 15 patients (14 males, 1 female) (age range, 40 to 67 years), histologically confirmed as schistosomal squamous cell carcinoma, were assessed for grade (G1, n = 3; G2, n = 7; G3, n = 5) and pathological stage (PT category: PT2, n = 4; PT3a, n = 9; PT3b, n = 2). Immunostaining was performed for mutant p53, bcl-2, HER2/neu, and MIB-1 (proliferation), using steam antigen retrieval and an avidin-biotin complex method. Frequency of strong immunoreactivity was high for mutant p53 (73%) and MIB-1 (87% intermediate or high) but low for bcl-2 (20%) and HER2/neu (27%). There was no significant correlation of any of the four markers with either grade or stage. Hence, schistosomal bladder squamous cell carcinoma is felt to be an aggressive carcinoma de novo. The high frequency of mutant p53 expression (73%) and an intermediate to high proliferation index (87%) suggests this. The lack of correlation between histological grade and all four markers studied suggests that grading is not of prognostic value.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14991535     DOI: 10.1016/j.humpath.2003.10.006

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

1.  Over-expression of HER-2 is associated with the stage in carcinomas of the urinary bladder.

Authors:  Khaled El Gehani; Lamia Al-Kikhia; Fatma Emaetig; Kari Syrjänen; Omran Al-Fituri; Adam Elzagheid
Journal:  Libyan J Med       Date:  2012-03-08       Impact factor: 1.657

2.  P53 and cancer-associated sialylated glycans are surrogate markers of cancerization of the bladder associated with Schistosoma haematobium infection.

Authors:  Júlio Santos; Elisabete Fernandes; José Alexandre Ferreira; Luís Lima; Ana Tavares; Andreia Peixoto; Beatriz Parreira; José Manuel Correia da Costa; Paul J Brindley; Carlos Lopes; Lúcio L Santos
Journal:  PLoS Negl Trop Dis       Date:  2014-12-11

3.  Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory study.

Authors:  Esmail M Al-Ezzi; Zachary W Veitch; Samer H Salah; Theodorus H Van der Kwast; Tracy L Stockley; Shamini Selvarajah; Tong Zhang; Srikala S Sridhar; Adrian G Sacher; Nazanin Fallah-Rad; Girish S Kulkarni; Alexandre R Zlotta; Antonio Finelli; Aaron R Hansen
Journal:  PLoS One       Date:  2021-12-01       Impact factor: 3.240

Review 4.  Programmed Cell Death-Ligand-1 expression in Bladder Schistosomal Squamous Cell Carcinoma - There's room for Immune Checkpoint Blockage?

Authors:  Ana C Madureira
Journal:  Front Immunol       Date:  2022-09-02       Impact factor: 8.786

5.  Schistosomiasis and urinary bladder cancer in North Western Tanzania: a retrospective review of 185 patients.

Authors:  Peter Fabian Rambau; Philipo L Chalya; Kahima Jackson
Journal:  Infect Agent Cancer       Date:  2013-05-24       Impact factor: 2.965

6.  Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumors.

Authors:  Ahmed S Abdulamir; Rand R Hafidh; Haider S Kadhim; Fatimah Abubakar
Journal:  J Exp Clin Cancer Res       Date:  2009-02-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.